Katten is a popular choice among financial institutions, asset managers, public companies and their executives, in the defense of a wide range of securities class actions, stockholder derivatives cases, M&A litigation, proxy disclosure suits and SEC investigations and enforcement actions. The life sciences sector remains a fertile source of work, with New York-based Bruce Vanyo regularly defending high-profile sector specific issuers, including with regard to cases brought following alleged misstatements (including with regard to clinical trials) and subsequent stock price drops. Chicago-based Michael Diver co-chairs the team alongside Vanyo and leverages his previous experience at the SEC to good effect to clients facing enforcement actions from the regulator, including with regard to financial fraud, market manipulation and insider trading. The arrival in March 2024 of New York-based Kevin Broughel from Paul Hastings LLP strengthens the team in light of his deep understanding of the financial markets, products and regulations, and for matters involving cross-border issues.
Legal 500 redaktioneller Kommentar
- Profil
Referenzen
Unabhängig vom Legal 500-Forschungsteam zusammengestellt.
- 'Bruce Vanyo is a really good negotiator, and an actual human being as well.'
- 'The Katten team, led by Mike Lohnes, was very accessible and experienced and employed great judgment.'
- 'I had the opportunity to work closely, albeit briefly, with Mike Lohnes, who is excellent. He was very experienced and has great judgment. Also, very down to earth and a pleasure.'
Kernmandanten
- Astra Space, Inc.
- BioNTech, SE
- BMO Capital Markets Corp.
- Brent Willis
- Coupa Software, Inc.
- CSG BSH Partners III,
- HAP Trading
- Inotiv, Inc.
- Land O’Frost
- Natera, Inc.
Highlight-Mandate
Defended PDVSA and PDVSA Petróleo (collectively, “PDVSA”) in a Section10(b) securities fraud lawsuit brought in the Southern District of New York in 2023 by an asset manager accusing PDVSA of fraud in connection with its issuance of nearly $2bn of senior secured notes in 2016.
Represents clinical genetic testing company Natera and certain current and former officers and directors in a securities class action lawsuit pending in the US District Court for the Western District of Texas. The lawsuit asserts claims under the Exchange Act (1934), SEC Rule10b-5 and the Securities Act (1933) based on allegedly misleading statements made by Natera in its public disclosures concerning the accuracy of Natera’s testing technology and the company’s growth projections.
Defending RBC Capital Markets in a lawsuit pending in the Delaware Court of Chancery (VC Laster) brought by a shareholder challenging a $1.37bn merger of two companies.
Anwält*innen
Hall of fame
Die Anwält*innen an der Spitze ihres Berufsstands, die aufgrund ihres langjährigen Engagements in marktführender Arbeit von Wettbewerbern und Mandanten gleichermaßen geschätzt und anerkannt werden.
Führende Partner*innen
Die stärksten Partner*innen ihres Praxisbereichs, die eine führende Rolle in signifikanten Mandaten einnehmen und weitreichende Anerkennung unter Wettbewerbern und Mandanten genießen.
Michael Diver
Praxisleitung
Bruce Vanyo
Weitere Kernanwält*innen
Michael Diver; Kevin Broughel; Sarah Eichenberger; Michael Lohnes; Jonathan Rotenberg